Association of Fcγ Receptor Polymorphisms with Adult Onset Still’s Disease in Korea
暂无分享,去创建一个
W. Chung | J. Choe | G. Song | D. Yoo | Jin-Hyun Woo | Jin‐sook Lee | Y. Sung | J. Woo
[1] N. Kutukculer,et al. Fc gamma RIIa, IIIa and IIIb polymorphisms in Turkish children susceptible to recurrent infectious diseases , 2006, Clinical and Experimental Medicine.
[2] R. Deutsch,et al. Fcγ receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor α–blocking agents , 2005 .
[3] T. Hsieh,et al. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. , 2004, The Journal of rheumatology.
[4] R. Geha,et al. IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy. , 2003, The Journal of allergy and clinical immunology.
[5] R. Wassmuth,et al. Fcγ receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms , 2002, Annals of the rheumatic diseases.
[6] C. Langefeld,et al. Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. , 2002, Arthritis and rheumatism.
[7] C. Vedeler,et al. Immunoglobulin G fc-receptor (FcgammaR) IIA, IIIA, and IIIB polymorphisms related to disease severity in rheumatoid arthritis. , 2002, The Journal of rheumatology.
[8] S. Bae,et al. Association Between FcgammaR IIa and IIIa polymorphism and clinical manifestations in Korean patients with adult-onset Still's disease. , 2002, Journal of Korean medical science.
[9] K. Neftel,et al. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes , 2001, American journal of hematology.
[10] L. van de Putte,et al. Role of Fc receptor gamma chain in inflammation and cartilage damage during experimental antigen-induced arthritis. , 2000, Arthritis and rheumatism.
[11] R. Kimberly,et al. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. , 1997, The Journal of clinical investigation.
[12] M. Akizuki,et al. Preliminary criteria for classification of adult Still's disease. , 1992, The Journal of rheumatology.
[13] J. Esdaile,et al. Adult Still's Disease: Manifestations, Disease Course, and Outcome in 62 Patients , 1991, Medicine.
[14] R. Deutsch,et al. Fcgamma receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor alpha-blocking agents. , 2005, Arthritis and rheumatism.
[15] E. Thomas,et al. Th1 and Th2 CD4 T Cells Provide Help for B Cell Clonal Expansion and Antibody Synthesis in a Similar Manner In Vivo , 2000 .
[16] M. Newkirk,et al. Aberrant cellular localization of rubella viral genome in patients with adult Still's disease--a pilot study. , 1993, Autoimmunity.